Kingworld Medicines Group Balance Sheet Health
Financial Health criteria checks 5/6
Kingworld Medicines Group has a total shareholder equity of CN¥756.7M and total debt of CN¥375.5M, which brings its debt-to-equity ratio to 49.6%. Its total assets and total liabilities are CN¥1.5B and CN¥754.9M respectively. Kingworld Medicines Group's EBIT is CN¥76.7M making its interest coverage ratio -409.9. It has cash and short-term investments of CN¥302.1M.
Key information
49.6%
Debt to equity ratio
CN¥375.46m
Debt
| Interest coverage ratio | -409.9x |
| Cash | CN¥302.10m |
| Equity | CN¥756.70m |
| Total liabilities | CN¥754.92m |
| Total assets | CN¥1.51b |
Recent financial health updates
Kingworld Medicines Group (HKG:1110) Takes On Some Risk With Its Use Of Debt
Oct 04
Kingworld Medicines Group (HKG:1110) Seems To Use Debt Rather Sparingly
Apr 24We Think Kingworld Medicines Group (HKG:1110) Can Stay On Top Of Its Debt
Dec 05Recent updates
Kingworld Medicines Group (HKG:1110) Takes On Some Risk With Its Use Of Debt
Oct 04Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To CN¥0.0338
May 31Even With A 26% Surge, Cautious Investors Are Not Rewarding Kingworld Medicines Group Limited's (HKG:1110) Performance Completely
May 22Investors Shouldn't Be Too Comfortable With Kingworld Medicines Group's (HKG:1110) Earnings
Apr 29Kingworld Medicines Group (HKG:1110) Will Pay A Larger Dividend Than Last Year At CN¥0.0338
Apr 23A Look At The Fair Value Of Kingworld Medicines Group Limited (HKG:1110)
Mar 22The Return Trends At Kingworld Medicines Group (HKG:1110) Look Promising
Nov 30Slowing Rates Of Return At Kingworld Medicines Group (HKG:1110) Leave Little Room For Excitement
Aug 17Kingworld Medicines Group (HKG:1110) Will Pay A Larger Dividend Than Last Year At CN¥0.0247
May 30The Returns At Kingworld Medicines Group (HKG:1110) Aren't Growing
May 11Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To CN¥0.0247
Apr 03Returns On Capital At Kingworld Medicines Group (HKG:1110) Paint A Concerning Picture
Feb 07A Look At The Fair Value Of Kingworld Medicines Group Limited (HKG:1110)
Oct 07Kingworld Medicines Group's (HKG:1110) Returns On Capital Not Reflecting Well On The Business
Jul 05Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To HK$0.024
Apr 27We Like These Underlying Return On Capital Trends At Kingworld Medicines Group (HKG:1110)
Aug 17Kingworld Medicines Group (HKG:1110) Seems To Use Debt Rather Sparingly
Apr 24Returns On Capital Are Showing Encouraging Signs At Kingworld Medicines Group (HKG:1110)
Mar 29Kingworld Medicines Group's (HKG:1110) Shareholders Are Down 46% On Their Shares
Mar 08Are Insiders Buying Kingworld Medicines Group Limited (HKG:1110) Stock?
Feb 15Should You Or Shouldn't You: A Dividend Analysis on Kingworld Medicines Group Limited (HKG:1110)
Jan 25
Will the Promising Trends At Kingworld Medicines Group (HKG:1110) Continue?
Dec 18We Think Kingworld Medicines Group (HKG:1110) Can Stay On Top Of Its Debt
Dec 05What We Learned About Kingworld Medicines Group's (HKG:1110) CEO Compensation
Nov 22Financial Position Analysis
Short Term Liabilities: 1110's short term assets (CN¥662.0M) exceed its short term liabilities (CN¥574.7M).
Long Term Liabilities: 1110's short term assets (CN¥662.0M) exceed its long term liabilities (CN¥180.2M).
Debt to Equity History and Analysis
Debt Level: 1110's net debt to equity ratio (9.7%) is considered satisfactory.
Reducing Debt: 1110's debt to equity ratio has increased from 40.5% to 49.6% over the past 5 years.
Debt Coverage: 1110's debt is well covered by operating cash flow (31.1%).
Interest Coverage: 1110 earns more interest than it pays, so coverage of interest payments is not a concern.